Radiotheranostics: Future of Therapy, Regulation & Access

Radiotheranostics is transforming oncology by combining precision imaging with targeted radioligand therapy.

To realise its full potential, challenges across the value chain from medical radionuclide supply and radiopharmaceutical drug development to clinical translation and implementation must be addressed. This Round Table brings together experts to discuss how science, industry and patient care can advance acceptance, meet regulatory requirements, improve patient access and maximise impact.